News | October 13, 2021
SecureKloud to list subsidiary Healthcare Triangle on Nasdaq
The company plans to raise US $ 15 million
The company plans to raise US $ 15 million
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
